Association of serum selenium with MASLD and liver fibrosis: A cross-sectional study
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0314780 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift PLOS ONE, 2024. Verfasst von Wenying Guo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Ningbo Medical Center Lihuili Hospital of Ningbo University, Ningbo, Zhejiang, People's Republic of China. Hauptthemen laut MEDLINE: Selenium, Liver Cirrhosis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The evolution of NAFLD, MAFLD, and MASLD underscores significant advancements and nomenclatural shifts in the realm of chronic liver disorders. This study primarily aimed to investigate the possible link between serum selenium levels and the occurrence of MASLD.
Methods
Utilizing data from NHANES for the years 2017 through 2020, we performed an in-depth analysis. To evaluate the relationship between serum selenium concentrations and the prevalence of MASLD and liver fibrosis, we employed a comprehensive multivariable analysis. This approach accounted for a range of variables to enhance the robustness and reliability of our results by mitigating potential confounding factors.
Results
Through the application of linear regression models, our comprehensive data analysis revealed significant insights. Elevated serum selenium levels exhibited a distinct positive correlation with CAP, whereas an inverse relationship with LSM was observed. Multivariate logistic regression analysis indicated that higher serum selenium concentrations were significantly associated with an increased likelihood of MASLD, alongside a marked reduction in the probability of liver fibrosis.
Conclusion
The findings of this study highlight a significant positive association between elevated serum selenium levels, CAP, and the prevalence of MASLD, coupled with an inverse relationship with LSM and liver fibrosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Ningbo Medical Center Lihuili Hospital of Ningbo University, Ningbo, Zhejiang, People's Republic of China.
ORCID-Profile: Yufei Song
Zitieren
APA
Guo, W., Weng, T., & Song, Y. (2024). Association of serum selenium with MASLD and liver fibrosis: A cross-sectional study. PLOS ONE. https://doi.org/10.1371/journal.pone.0314780
Vancouver
Guo W, Weng T, Song Y. Association of serum selenium with MASLD and liver fibrosis: A cross-sectional study. PLOS ONE. 2024. doi:10.1371/journal.pone.0314780
BibTeX
@article{Guo2024,
author = {Guo, Wenying and Weng, Ting and Song, Yufei},
title = {Association of serum selenium with MASLD and liver fibrosis: A cross-sectional study},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0314780}
}
EUVIMED